Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Veracyte (NASDAQ:VCYT – Get […]
Sumitomo Mitsui Trust Holdings Inc. cut its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,104,676 shares of the biotechnology company’s stock after selling 68,900 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about […]
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The average 12 […]
William Blair reiterated their outperform rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research report sent to investors on Friday, RTT News reports. William Blair also issued estimates for Veracyte’s Q2 2025 earnings at ($0.01) EPS and FY2025 earnings at $0.00 EPS. A number of other brokerages have also issued reports on […]
Veracyte (NASDAQ:VCYT – Get Free Report) had its price target lifted by Needham & Company LLC from $30.00 to $33.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 35.58% from the […]